Cloning and immunologic characterization of a truncated Bordetella bronchiseptica filamentous hemagglutinin fusion protein

Vaccine

Volumn 18, Issue 9-10, 1999, Pages 860-867

  Keil, Daniel J ^a   Burns Jr , Eugene H ^b   Kisker, William R ^c   Bemis, David ^d   Fenwick, Brad ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b SHAWNEE STATE UNIVERSITY   (United States)

^c DREW UNIVERSITY   (United States)

^d UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Bordetella bronchiseptica; Canine; FHA; Filamentous hemagglutinin

Indexed keywords

ANTIGEN; ANTISERUM; HEMAGGLUTININ; HYBRID PROTEIN; VACCINE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGENICITY; ARTICLE; BORDETELLA BRONCHISEPTICA; CELL ADHESION; CLONING; CONTROLLED STUDY; DNA LIBRARY; DNA SEQUENCE; DOG; FIBROBLAST; HEMAGGLUTINATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

ADHESINS, BACTERIAL; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL ADHESION; BASE SEQUENCE; BORDETELLA BRONCHISEPTICA; CLONING, MOLECULAR; DOGS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININS; IMMUNODOMINANT EPITOPES; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; RABBITS; RECOMBINANT FUSION PROTEINS; VIRULENCE FACTORS, BORDETELLA;

EID: 0032722362     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00322-9     Document Type: Article

References (30)

1. Finlay B.B., Falkow S. Common themes in microbial pathogenicity revisited. Microbiol. Mol. Biol. Rev. 61:1997;136-169.
2. Cherry J.D. J. Infect. Historical review of pertussis and the classical vaccine. J. Infect. Dis. 174:(Suppl. 3):1996;S259-S263.
3. Bemis D.A., Greisen H.A., Appel M.J.G. Pathogenesis of canine bordetellosis. J. Infect. Dis. 135:1977;753-762.
4. Brennan M.J., Shahin S. Pertussis antigens that abrogate bacterial adherence and elicit immunity. Am. J. Respir. Crit. Care Med. 154:1996;S145-S149.
5. Podda A., De Luca E.C., Titone L., Casadei A.M., Cascio A., Bartalini M., Volpini G., Peppoloni S., Marsili I., Nencioni L., Rappuoli R. Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children. J. Pediatr. 123:1993;81-84.
6. Podda A., De Luca E.C., Titone L., Casadei A.M., Cascio A., Peppoloni S., Volpini G., Marsili I., Nencioni L., Rappuoli R. Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: safety and immunogenicity in 12- to 24- and 2- to 4-month-old children. J. Pediatr. 120:1992;680-685.
7. Pichichero M.E., Deloria M.A., Rennels M.B., Anderson E.L., Edwards K.M., Decker M.D., Englund J.A., Steinhoff M.C., Deforest A., Meade B.D. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children. Pediatrics. 100:1997;772-788.
8. Greco D., Salmaso S., Mastrantonio P., Giuliano M., Tozzi A.E., Anemona A., Ciofi degli Atti M.L., Giammanco A., Panei P., Blackwelder W.C., Klein D.L., Wassilak S.G. Controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N. Engl. J. Med. 334:1996;341-348.
9. Keil D.J., Fenwick B. Evaluation of canine Bordetella bronchiseptica isolates using randomly amplified polymorphic DNA fingerprinting and ribotyping. Vet. Microbiol. 66:1999;41-51.
10. Keil DJ, Fenwick B. Strain- and growth condition-dependent variability in outer membrane protein expression by Bordetella bronchiseptica isolates from dogs. Am J Vet Res, in press.
11. Keil D.J., Fenwick B. Role of Bordetella bronchiseptica in infectious tracheobronchitis in dogs. J. Am. Vet. Med. Assoc. 212:1998;200-207.
12. Leininger E., Bowen S., Renauld-Mongen G., Rouse J.H., Menozzi F.D., Locht C., Heron I., Brennan M.J. Immunodominant domain present on the Bordetella pertussis vaccine component filamentous hemagglutinin. J. Infect. Dis. 175:1997;1423-1431.
13. Wilson D.R., Siebers A., Finlay B.B. Antigenic analysis of Bordetella pertussis filamentous hemagglutinin with phage display libraries and rabbit anti-filamentous hemagglutinin polyclonal antibodies. Infect. Immun. 66:1998;4884-4894.
14. Domenighini M., Relman D., Capiau C., Falkow S., Prugnola A., Scarlato V., Rappuoli R. Genetic characterization of Bordetella pertussis filamentous hemagglutinin: a protein processed from an unusually large precursor. Mol. Microbiol. 4:1990;787-800.
15. Locht C., Bertin P., Menozzi F.D., Renauld G. The filamentous hemagglutinin, a multifaceted adhesin produced by virulent Bordetella spp. Mol. Microbiol. 9:1993;653-660.
16. Ishibashi Y., Claus S., Relman D.A. Bordetella pertussis filamentous hemagglutinin interacts with a leukocyte signal transduction complex and stimulates bacterial adherence to monocyte CR3 (CD11b/CD18). J. Exp. Med. 180:1994;1225-1233.
17. Hannah J.H., Menozzi F.D., Renauld G., Locht C., Brennan M.J. Sulfated glycoconjugate receptors for the Bordetella pertussis adhesin filamentous hemagglutinin (FHA) and mapping of the heparin-binding domain on FHA. Infect. Immun. 62:1994;5010-5019.
18. Prasad S.M., Yin Y., Rodzinski E., Tuomanen E.I., Masure H.R. Identification of a carbohydrate recognition domain in filamentous hemagglutinin from Bordetella pertussis. Infect. Immun. 61:1993;2780-2785.
19. Cotter P.A., Yuk M.H., Mattoo S., Akerley B.J., Boschwitz J., Relman D.A., Miller J.F. Filamentous hemagglutinin of Bordetella bronchiseptica is required for efficient establishment of tracheal colonization. Infect. Immun. 66:1998;5921-5929.
20. Leininger E., Probst P.G., Brennan M.J., Kenimer J.G. Inhibition of Bordetella pertussis filamentous hemagglutinin-mediated cell adherence with monoclonal antibodies. FEMS Microbiol. Lett. 106:1993;31-38.
21. Ohgitani T., Okabe T., Sasaki N. Characterization of hemagglutinin from Bordetella bronchiseptica. Vaccine. 9:1991;653-658.
22. Immunoblotting. Harlow E., Lane D. Antibodies: a laboratory manual. 1988;171-210 John Wiley & Sons, New York, NY.
23. Mierendorf R.C., Pfeffer D. Direct sequencing of denatured plasmid DNA. Methods Enzymol. 152:1987;556-562.
24. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
25. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:1994;4673-4680.
26. The QIA expressionist. 1997;Qiagen Inc, Valencia, CA.
27. Porath J., Carlsson J., Belfrage G. Metal chelate affinity chromatography, a new approach to protein fractionation. Nature. 258:1975;598-599.
28. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:1997;3389-3402.
29. Tuomanen E.I., Zapiain L.A., Galvan P., Hewlett E.L. Characterization of antibody inhibiting adherence of Bordetella pertussis to human respiratory epithelial cells. J. Clin. Microbiol. 20:1984;167-170.
30. van den Berg B.M., Beekuhizen H., Mooi F.R., van Furth R. Role of antibodies against Bordetella pertussis virulence factors in adherence of Bordetella pertussis and Bordetella parapertussis to human bronchial epithelial cells. Infect. Immun. 67:1999;1050-1055.